Pulmonx Co. (NASDAQ:LUNG) Given Average Recommendation of “Moderate Buy” by Analysts
Shares of Pulmonx Co. (NASDAQ:LUNG – Get Free Report) have earned an average recommendation of “Moderate Buy” from the nine analysts that are presently covering the company, Marketbeat.com reports. Two analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average twelve-month price target among […]
Shares of Pulmonx Co. (NASDAQ:LUNG – Get Free Report) have earned an average recommendation of “Moderate Buy” from the nine analysts that are presently covering the company, Marketbeat.com reports. Two analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average twelve-month price target among […]
